Napabucasin (BBI608) is a small molecule inhibitor of STAT3 evaluated for the treatment of several cancers including platinum-resistant ovarian cancer, gastric adenocarcinoma, and pancreatic cancer [99]. Here, STAT3 is linked to pancreatic neoplasm.